News | Mobile Devices | May 22, 2017

Consumers Warned About Accuracy of Heart Rate Apps in New Study

European analysis of four commercially available heart rate apps finds contact apps more accurate than non-contact; however variation exists between contact apps

Consumers Warned About Accuracy of Heart Rate Apps in New Study

May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability between commercially available mobile apps, even those using the same technology. The research was published in the European Journal of Preventive Cardiology.

“Heart rate apps come installed on many smartphones and once people see them it is human nature to use them and compare their results with others,” said last author Christophe Wyss, M.D., a cardiologist at Heart Clinic Zurich, Switzerland. “The problem is that there is no law requiring validation of these apps and therefore no way for consumers to know if the results are accurate.”

This study tested the accuracy of four commercially available heart rate apps (randomly selected) using two phones, the iPhone 4 and iPhone 5. Some apps use contact photoplethysmography (touching fingertip to the phone’s built-in camera), while other apps use non-contact photoplethysmography (camera is held in front of the face).

Accuracy was assessed by comparing the results to the clinical gold-standard measurements of electrocardiograms (ECG) and fingertip pulse oximetry.

The study included 108 patients who had their heart rate measured by ECG, pulse oximetry, and each app using each phone.

The researchers found substantial differences in accuracy between the four apps. In some apps there were differences of more than 20 beats per minute compared to ECG in over 20 percent of the measurements. The non-contact apps performed less well than the contact apps, particularly at higher heart rates and lower body temperatures. The non-contact apps had a tendency to overestimate higher heart rates.

Wyss said, “While it’s easy to use the non-contact apps – you just look at your smartphone camera and it gives your heart rate – the number it gives is not as accurate as when you have contact with your smartphone by putting your fingertip on the camera.”

But the performance of the two contact apps was also different. One app measured heart rate with comparable accuracy to pulse oximetry, but the other app did not give the correct measurement.

“The one contact app was excellent, performing almost like a medically approved pulse oximeter device, but the other app was not accurate even though they use the same technology,” said Wyss.

The researchers tried to find the reason for the difference in performance between the two contact apps. But they found that the variation could not be explained by camera technology (iPhone 4 versus iPhone 5), age, body temperature or heart rate itself.

“The difference in performance between the contact apps is probably down to the algorithm the app uses to calculate heart rate, which is commercially confidential,” said Wyss. “It means that just because the underlying technology works in one app doesn’t mean it works in another one and we can’t assume that all contact heart rate apps are accurate.”

Wyss said, “Before you measure your heart rate have a specific question in mind, don’t just measure it for fun. For example, ‘Is my heart rate too high when I feel something strange in my heart?’ or ‘Is it too low when I feel dizzy?’.”

He concluded: “Consumers and interpreting physicians need to be aware that the differences between apps are huge and there are no criteria to assess them. We also don’t know what happens to the heart rate data and whether it is stored somewhere, which could be an issue for data protection.”

For more information: www.journals.sagepub.com/home/cpr

Related Content

HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG| August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging| August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
Overlay Init